Medical Action Industries acquires AVID Medical

NewsGuard 100/100 Score

Medical Action Industries Inc. (NASDAQ: MDCI) announced the acquisition of AVID Medical, Inc., a leading provider of custom procedure trays serving the healthcare industry. AVID's product line of custom procedure trays is complementary to Medical Action's leading position in single use medical products. Medical Action expects that the acquisition will increase its ability to serve healthcare providers in acute care facilities and surgery centers. The combined competencies, clinical expertise and extensive healthcare industry knowledge of both organizations should enhance the company's ability to provide comprehensive and innovative solutions that enable healthcare providers to improve patient care while optimizing clinical and economic outcomes.

"This strategic acquisition strengthens Medical Action's core capabilities in developing, manufacturing and delivering quality medical products to hospitals and healthcare institutions," said Paul D. Meringolo, CEO and Chairman of the Board of Medical Action Industries Inc. "The addition of custom procedure trays increases the breadth and depth of our product offerings and progresses us toward our initial goal of attaining $500 million in revenues. AVID reported sales of custom procedure trays of approximately $136 million during its most recent fiscal year ended March 31, 2010 within a market segment that we estimate to be in excess of $2 billion. This transaction enhances our leadership position and relevancy within our markets and is another step forward in positioning ourselves for future growth. We also continue to invigorate our sales and marketing capabilities and are excited to execute on our strategy to increase our product offerings. We expect that the market will continue to receive excellent customer service augmented by AVID's ability to deliver true custom solutions designed to meet the needs of healthcare providers, while enhancing clinicians' abilities to access Medical Action's extensive product portfolio."

Medical Action has paid $62.5 million in cash, excluding transaction costs, for AVID. Medical Action expects the transaction to be accretive to earnings during the fiscal year ending March 31, 2011, excluding the impact of non-recurring acquisition related and integration costs. Medical Action also expects to achieve significant cost savings and efficiencies driven by the combination of the two companies' national sales forces which will create broader sales channels, increased service coverage, and dedicated focus to clinical and patient care products.

In connection with the closing of the acquisition, Michael Sahady founder and CEO of AVID, will join Medical Action's Board of Directors. AVID's President and Chief Operating Officer Richard Setian, will assume the role of Vice President of Sales and Marketing leading the newly formed sales organization. Meringolo added, "As a result of this transaction, Medical Action's sales will increase by approximately 45 percent and we believe that the company will achieve a greater national presence. The custom procedure trays market segment also presents opportunities for us to increase sales of our existing product lines to current and new customers, while expanding our portfolio with additional medical devices. This will enable us to drive sales through a focused approach on promoting both our clinical and patient care products."

Source:

Medical Action Industries Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Empowering Change: How Hologic is Shaping the Future of Women's Healthcare